Sculptor Capital's Investment Activity in Q3 2026: Key Purchases and Sales
Sculptor Capital analyzed its portfolio holdings as of June 30, 2026. The report highlights significant changes including large purchases in several Technology stocks.

As part of our ongoing financial analysis for Sculptor Capital Lp (check out their institutional profile here) and other major investors, we've examined the latest filing dated 2026-06-30. This document provides valuable insights into Sculptor Capital's investment activity during Q3 2026.
The data reveals a dynamic quarter for Sculptor Capital, with notable shifts in their portfolio allocations across various sectors. The total portfolio value stood at $5.31 billion as of the reporting date, reflecting changes from previous periods.
Prominent Technology Buys
Sculptor Capital demonstrated a strong focus on acquiring high-profile Technology stocks this quarter. TSM (TAIWAN SEMICONDUCTOR MANUFAC) saw its position significantly boosted, with shares increasing by 299.38% from the prior period (TSM details). Similarly, META (META PLATFORMS INC), also known as Meta, experienced a massive increase of over 200% in its holdings (META profile).
The investor's Technology allocation remains substantial. Besides TSM and META, other significant purchases include AMD (ADVANCED MICRO DEVICES INC), which saw a 100% increase in shares (AMD data). Furthermore, holdings in MU (MICRON TECHNOLOGY INC) and MSFT (MICROSOFT CORP), both Technology giants, also increased by 100% (MU info) and (MSFT profile), respectively.
Healthcare Sector Focus
The Healthcare sector also attracted considerable attention from Sculptor Capital. Shares of SOTERA HEALTH CO (SHC), a Healthtech company, increased by 10.51% (SHC details). Another notable addition was BRUKER CORP (BRKR), which saw its stake grow significantly by 41.44%, driven by a large increase in shares (BRKR profile). Both companies are prominent players within the Healthcare space.
Interestingly, some existing holdings were also increased substantially. APO-A (APOLLO GLOBAL MGMT INC), though categorized as Unknown in this data snippet, is a major investment vehicle often held by Sculptor Capital and saw its stake grow by 53.56% (APO-A profile). Additionally, the investor added positions to INFY (INFOSYS LTD), a Technology company specializing in IT services (INFY data), and AER (AERCAP HOLDINGS NV), an airline holding company (AER profile). These additions further diversify their Healthcare exposure.
Mixed Signals in Other Sectors
While Technology and Healthcare showed net buying interest, the data also indicates selling activity or reduced allocations elsewhere. For instance, KVUE (KENVUE INC), a Consumer Defensive stock, experienced a sharp decline of over 68% (KVUE profile). Similarly, there was a significant reduction in holdings of SATS (ECHOSTAR CORP), another Technology-related stock, with shares down by nearly 44% (SATS data). The investor also completely exited their position in AIRS (AIRSCULPT TECHNOLOGIES INC), reducing its allocation to zero (AIRS profile).
In terms of sector allocations, Technology remains the largest holding for Sculptor Capital at 33.21% as of June 30th. Communication Services and Healthcare follow closely with significant portions allocated to these sectors (Sculptor Capital institutional profile). The remaining allocations are distributed across various other sectors, including Financial Services (6.18%), Industrials (4.88%), Consumer Cyclical (2.94%), and smaller categories like Utilities (0.0%) and Real Estate (0.59%).
Overall Portfolio Insights
The filing shows Sculptor Capital managing a diverse portfolio with 93 holdings as of the end of Q3 2026. The top five positions account for approximately 20% of the total value, indicating concentration in key sectors despite overall diversification.
Key indicators from this report include substantial buying activity (highlighted by 'has_large_buys': true) and significant selling or reduction activities ('has_large_sells': true). The investor's focus appears to be on high-growth Technology companies, while they are also strategically adding positions in Healthcare. Conversely, they have reduced exposure to certain Consumer Defensive stocks.